Paper Details

Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the A 3-Year Study of Candida Infections Among Patients With Malignancy: Etiologic Agents and Antifungal Susceptibility Profile

Hamed Fakhim

Hamed Fakhim

Assistant Professor of Medical Mycology

Infectious Diseases and Tropical Medicine Research Center

Isfahan University of Medical Sciences

Related Documents

1. Species Distribution and Susceptibility Profiles of Oral Candidiasis in Hematological Malignancy and Solid Tumor Patients, Brazilian Journal of Microbiology (2023)

2. In Vitro Activity of Juglone (5-Hydroxy-1,4-Naphthoquinone) Against Both Fluconazole-Resistant and Susceptible Candida Isolates; [Actividad in Vitro De Juglona (5-Hidroxi-1,4-Naftoquinona) Contra Aislamientos De Candida Resistentes Y Sensibles a Fluconazol], Revista Iberoamericana de Micologia (2022)

3. In-Vivo Efficiency of the Novel Azole Compounds (Attaf-1 and Attaf-2) Against Systemic Candidiasis in a Murine Model, Journal of Medical Mycology (2023)

4. Yeast Species in the Respiratory Samples of Covid-19 Patients; Molecular Tracking of Candida Auris, Frontiers in Cellular and Infection Microbiology (2024)

5. Catheter-Associated Blood Stream Infections Due to Candida Pararugosa in a Patient With Acute Myeloid Leukemia: A Case Report, Brazilian Journal of Microbiology (2023)

6. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex, Mycopathologia (2016)

7. Candida Africana Vulvovaginitis: Prevalence and Geographical Distribution, Journal de Mycologie Medicale (2020)

8. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators Against 354 Molecularly Identified Aspergillus Isolates, Mycopathologia (2020)

9. Trends in the Prevalence of Amphotericin B-Resistance (Ambr) Among Clinical Isolates of Aspergillus Species, Journal of Medical Mycology (2022)

All Documents

1. Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran, Journal of Medical Mycology (2024)

2. Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran, Journal of Medical Mycology (2024)

3. Quantitative Real Time Pcr for Distinction Between Pneumocystis Jirovecii Infection/Colonization in Hospitalized Patients, Frontiers in Cellular and Infection Microbiology (2024)

4. Synthesis and Antifungal Activity Evaluation of a Fluconazole Analog Derived From Dithiocarbamate, Journal of Mazandaran University of Medical Sciences (2024)

5. Yeast Species in the Respiratory Samples of Covid-19 Patients; Molecular Tracking of Candida Auris, Frontiers in Cellular and Infection Microbiology (2024)

6. Bioassay-Guided Isolation in Salvia Abrotanoides Karel. Stem Based on Its Anti-Fungal and Anti-Trichomonas Activity, Research in Pharmaceutical Sciences (2023)

7. Catheter-Associated Blood Stream Infections Due to Candida Pararugosa in a Patient With Acute Myeloid Leukemia: A Case Report, Brazilian Journal of Microbiology (2023)

8. Design, Synthesis and Biological Activity of Hybrid Antifungals Derived From Fluconazole and Mebendazole, European Journal of Medicinal Chemistry (2023)

9. Efficacy of Hydroxychloroquine in Pre-Exposure Severe Acute Respiratory Syndrome Coronavirus 2 Prophylaxis Among High-Risk Healthcare Workers: A Multicenter Study, Advanced Biomedical Research (2023)

10. Identification of Polyphenolic Compounds Responsible for Antioxidant, Anti-Candida Activities and Nutritional Properties in Different Pistachio (Pistacia Vera L.) Hull Cultivars, Molecules (2023)

11. Implementation of an In-House Platform for Rapid Screening of Sars-Cov-2 Genome Variations, Archives of Iranian Medicine (2023)

12. Implementation of an In-House Platform for Rapid Screening of Sars-Cov-2 Genome Variations, Archives of Iranian Medicine (2023)

13. In-Vivo Efficiency of the Novel Azole Compounds (Attaf-1 and Attaf-2) Against Systemic Candidiasis in a Murine Model, Journal of Medical Mycology (2023)

14. Molecular and Microscopy Detection of Pneumocystis Jirovecii in Hospitalized Patients During the Covid-19 Pandemic, Frontiers in Medicine (2023)

15. Pulmonary Function, Anxiety, Depression, and Sleep Quality After Recovery From Covid-19, Tanaffos (2023)

16. Species Distribution and Susceptibility Profiles of Oral Candidiasis in Hematological Malignancy and Solid Tumor Patients, Brazilian Journal of Microbiology (2023)

17. The Seroprevalence and Seropositivity of Sars-Cov-2 Among Healthcare Workers During the Third Pandemic Wave, Antibodies (2023)

18. A Chronic Autochthonous Fifth Clade Case of Candida Auris Otomycosis in Iran, Mycopathologia (2022)

19. Ct Findings of Covid-19-Associated Pulmonary Aspergillosis: A Systematic Review and Individual Patient Data Analysis, Clinical Imaging (2022)

20. Disease Waves of Sars-Cov-2 in Iran Closely Mirror Global Pandemic Trends, Archives of Iranian Medicine (2022)

21. Disease Waves of Sars-Cov-2 in Iran Closely Mirror Global Pandemic Trends, Archives of Iranian Medicine (2022)

22. Fusarium Proliferatum-Induced Chronic Lip Ulcer: Successful Treatment With Itraconazole: A Case Report, Journal of Medical Case Reports (2022)

23. Fusarium Proliferatum-Induced Chronic Lip Ulcer: Successful Treatment With Itraconazole: A Case Report, Journal of Medical Case Reports (2022)

24. In Vitro Activity of Juglone (5-Hydroxy-1,4-Naphthoquinone) Against Both Fluconazole-Resistant and Susceptible Candida Isolates; [Actividad in Vitro De Juglona (5-Hidroxi-1,4-Naftoquinona) Contra Aislamientos De Candida Resistentes Y Sensibles a Fluconazol], Revista Iberoamericana de Micologia (2022)

25. Melting Curve-Based Assay As an Alternative Technique for the Accurate Detection of Sars-Cov-2, Advanced Biomedical Research (2022)

26. On Admission Hemoglobin and Albumin, As the Two Novel Factors Associated With Thrombosis in Covid-19 Pneumonia, Journal of Renal Injury Prevention (2022)

27. Prevalence of Human T-Lymphotropic Virus Type 1 in Brain-Dead Organ Donors, Archives of Clinical Infectious Diseases (2022)

28. The Correlation Between Viral Shedding Duration and Blood Biomarkers in Covid-19-Infected Patients, Journal of Research in Medical Sciences (2022)

29. Trends in the Prevalence of Amphotericin B-Resistance (Ambr) Among Clinical Isolates of Aspergillus Species, Journal of Medical Mycology (2022)

30. Trends in the Prevalence of Amphotericin B-Resistance (Ambr) Among Clinical Isolates of Aspergillus Species, Journal of Medical Mycology (2022)

31. Asymptomatic Carriers of Coronavirus Disease 2019 Among Healthcare Workers in Isfahan, Iran, Future Virology (2021)

32. Asymptomatic Carriers of Coronavirus Disease 2019 Among Healthcare Workers in Isfahan, Iran, Future Virology (2021)

33. Direct Detection and Identification of the Most Common Bacteria and Fungi Causing Otitis Externa by a Stepwise Multiplex Pcr, Frontiers in Cellular and Infection Microbiology (2021)

34. Direct Detection and Identification of the Most Common Bacteria and Fungi Causing Otitis Externa by a Stepwise Multiplex Pcr, Frontiers in Cellular and Infection Microbiology (2021)

35. Fatal Disseminated Aspergillosis in an Immunocompetent Patient With Covid-19 Due to Aspergillus Ochraceus, Journal of Medical Mycology (2021)

36. Frequency of Occurrence, Seasonal Variation and Antifungal Susceptibility of Opportunistic Mucorales Isolated From Hospital Soils in Iran, Mycoses (2021)

37. Strategies for Isothermal Amplification of Nucleic Acids: Are They Ready to Be Applied in Point of Care Diagnosis of Mycosis?, Biointerface Research in Applied Chemistry (2021)

38. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators Against 354 Molecularly Identified Aspergillus Isolates, Mycopathologia (2020)

39. Candida Africana Vulvovaginitis: Prevalence and Geographical Distribution, Journal de Mycologie Medicale (2020)

40. Fatal Invasive Pulmonary Aspergillosis in Covid-19 Patient With Acute Myeloid Leukemia in Iran, Mycopathologia (2020)

41. Rapid and Low-Cost Culture-Based Method for Diagnosis of Mucormycosis Using a Mouse Model, Frontiers in Microbiology (2020)

42. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)

43. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)

44. In Vitro Activity of Nine Antifungal Agents Against a Global Collection of Hortaea Werneckii Isolates, the Agent of Tinea Nigra, International Journal of Antimicrobial Agents (2019)

45. Indifferent Effect of Nonsteroidal Anti-Inflammatory Drugs (Nsaids) Combined With Fluconazole Against Multidrug-Resistant Candida Auris, Current Medical Mycology (2019)

46. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)

47. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)

48. Frequency and Geographic Distribution of Card9 Mutations in Patients With Severe Fungal Infections, Frontiers in Microbiology (2018)

49. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

50. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

51. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

52. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

53. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

54. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

55. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

56. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

57. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

58. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

59. In Vitro Antifungal Activity of Amphotericin B and 11 Comparators Against Aspergillus Terreus Species Complex, Mycoses (2018)

60. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

61. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

62. Pesticide Behavior in Paddy Fields and Development of Azole-Resistant Aspergillus Fumigatus: Should We Be Concerned?, Journal de Mycologie Medicale (2018)

63. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

64. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

65. Severe Disseminated Phaeohyphomycosis in a Patient With Inherited Card9 Deficiency, Archives of Clinical Infectious Diseases (2018)

66. Epidemiological and Mycological Characteristics of Candidemia in Iran: A Systematic Review and Meta-Analysis; [Caracteristiques Epidemiologiques Et Mycologiques De La Candidemie En Iran : Revue Systematique Et Meta-Analyse], Journal de Mycologie Medicale (2017)

67. An Overview of Allergic Bronchopulmonary Aspergillosis; Diagnostic and Therapeutic Aspects, Journal of Mazandaran University of Medical Sciences (2016)

68. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex, Mycopathologia (2016)

69. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex, Mycopathologia (2016)

70. In Vitro Susceptibility Profiles of Eight Antifungal Drugs Against Clinical and Environmental Strains of Phaeoacremonium, Antimicrobial Agents and Chemotherapy (2015)

71. The First Case of Onychomycosis Due to Aspergillus Uvarum (Section Nigri), Mycoses (2015)